Search research articles
Contact Us
Filters
Showing results (71-80 of 244) with videos related to
Page
of 25
Sort By:
Plos One
|
October 8, 2016
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice
Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 15, 2005
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients
Antonella d'arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
HIV Medicine
|
June 5, 2024
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy
Vincenzo Malagnino, Alessandro Cozzi-Lepri, Valentina Svicher, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
Antonella D'arminio Monforte, Alessandro Tavelli, Matteo Sala, et al.
The Journal of Antimicrobial Chemotherapy
|
September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort
Alessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 23, 2019
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort
Antonella d'Arminio Monforte, Alessandro Tavelli, Alessandro Cozzi-Lepri, et al.
Open Forum Infectious Diseases
|
May 22, 2026
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort
Alessandra Vergori, Adriana Cervo, Ashley Roen, et al.
Scientific Reports
|
May 6, 2021
Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss
Cristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
BMC Infectious Diseases
|
June 25, 2021
Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
Esther Merlini, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 17, 2021
Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA Cohort
Andrea Giacomelli, Alessandro Cozzi-Lepri, Antonella Cingolani, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 244) with videos related to
Sort By:
Page
of 25
Plos One
|
October 8, 2016
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice
Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 15, 2005
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients
Antonella d'arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
HIV Medicine
|
June 5, 2024
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy
Vincenzo Malagnino, Alessandro Cozzi-Lepri, Valentina Svicher, et al.
The Journal of Antimicrobial Chemotherapy
|
February 13, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
Antonella D'arminio Monforte, Alessandro Tavelli, Matteo Sala, et al.
The Journal of Antimicrobial Chemotherapy
|
September 23, 2025
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort
Alessandra Vergori, Alessandro Cozzi-Lepri, Sergio Lo Caputo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 23, 2019
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort
Antonella d'Arminio Monforte, Alessandro Tavelli, Alessandro Cozzi-Lepri, et al.
Open Forum Infectious Diseases
|
May 22, 2026
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort
Alessandra Vergori, Adriana Cervo, Ashley Roen, et al.
Scientific Reports
|
May 6, 2021
Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss
Cristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
BMC Infectious Diseases
|
June 25, 2021
Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV
Esther Merlini, Alessandro Cozzi-Lepri, Antonella Castagna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 17, 2021
Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA Cohort
Andrea Giacomelli, Alessandro Cozzi-Lepri, Antonella Cingolani, et al.
Page
of 25